the determination of serum c-peptide has been found to be a sensitive indicator of endogenous insulin secretion , and serves to define diabetic patients who require insulin therapy i.e. , insulin-dependent ( type i , iddm ) and those non-insulin dependent ( type ii , niddm ) .
C0021641
insulin
C0011860
niddm